Men with immunoglobulin G4 (IgG4)-related disease exhibit significantly lower serum lipase levels and a greater likelihood of organ involvement than women, highlighting significant sex-dependent ...
The incidence of IgG4-related disease in the U.S. is similar to that of other systemic rheumatic diseases, like systemic sclerosis. In the new analysis, the research team identified 524 cases of ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — The role of IgG4 itself in IgG4 disease remains unclear, one of the many unexplained components ...
Please provide your email address to receive an email when new articles are posted on . The FDA on Thursday gave the green light to Uplizna in IgG4-related disease, making it the first and only ...
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD). An international, ...
Advances Amgen's Leadership in CD19 Directed, B-Cell Depletion Therapies for Serious Autoimmune Diseases Including NMOSD, IgG4-RD and gMG IgG4-RD can occur in multiple organs and lead to fibrosis and ...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the therapeutic indication of Uplizna (inebilizumab, Amgen Europe) to include ...
The Key IgG4-related Disease Companies in the market include - Zenas BioPharma, Horizon Therapeutics, Amgen, Sanofi, UMC Utrecht, and others. DelveInsight’s “IgG4-related Disease Market Insights, ...
In a recent study posted to bioRxiv* preprint server, researchers in Germany assessed the differences in antigen-specific immunoglobulin G (IgG) subtypes between post-COVID syndrome (PCS) patients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback